TWO SIGMA INVESTMENTS, LP - HARPOON THERAPEUTICS INC ownership

HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 70 filers reported holding HARPOON THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of HARPOON THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$30,632
-27.9%
43,144
-24.4%
0.00%
Q1 2023$42,479
+32.7%
57,080
+71.1%
0.00%
Q3 2022$32,000
-13.5%
33,361
+73.6%
0.00%
Q2 2022$37,000
-95.8%
19,212
-83.6%
0.00%
-100.0%
Q4 2021$887,000
-72.4%
117,442
-71.1%
0.00%
-71.4%
Q3 2021$3,211,000
+556.6%
406,470
+1311.4%
0.01%
+250.0%
Q3 2020$489,000
+1.5%
28,800
-0.8%
0.00%0.0%
Q2 2020$482,000
+3.4%
29,022
-27.9%
0.00%
-50.0%
Q1 2020$466,000
-20.3%
40,232
+1.7%
0.00%
+100.0%
Q4 2019$585,00039,5510.00%
Other shareholders
HARPOON THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 3,156,699$66,038,00015.37%
MPM ASSET MANAGEMENT LLC 3,238,306$67,745,00013.09%
MPM BioImpact LLC 3,898,422$81,555,00010.25%
Aquilo Capital Management, LLC 1,554,199$32,514,0005.88%
Altium Capital Management LP 199,607$4,176,0001.16%
SECTORAL ASSET MANAGEMENT INC 631,050$13,202,0001.00%
Avidity Partners Management LP 1,408,000$29,455,0000.81%
DAFNA Capital Management LLC 126,663$2,650,0000.63%
Logos Global Management LP 300,000$6,276,0000.61%
Orbimed Advisors 2,285,704$47,817,0000.45%
View complete list of HARPOON THERAPEUTICS INC shareholders